Phase III clinical trial of JTE-350 - Skin Prick Test of JTE-350 in Healthy Volunteers
Phase 3
- Conditions
- Positive control of Skin Prick Test for allergy diagnosis
- Registration Number
- JPRN-jRCT2080222252
- Lead Sponsor
- TORII PHARMACEUTICAL CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
1) Healthy Volunteers 20 to 65 years of age on the day of informed consent
2) Subjects signed written informed consent
Exclusion Criteria
1) Subjects with a history of serious drug allergy or subjects who have ever experienced systemic allergy due to skin prick test.
2) Subjects with treatmets to affect skin prick test result, for example anti-histamine drug
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Positive rate of JTE-350<br>After 15 minutes, the wheal diameter is 3mm or longer
- Secondary Outcome Measures
Name Time Method